Microfluidics‐based 3D cell culture models: Utility in novel drug discovery and delivery research

The implementation of microfluidic devices within life sciences has furthered the possibilities of both academic and industrial applications such as rapid genome sequencing, predictive drug studies, and single cell manipulation. In contrast to the preferred two‐dimensional cell‐based screening, thre...

Full description

Saved in:
Bibliographic Details
Published inBioengineering & translational medicine Vol. 1; no. 1; pp. 63 - 81
Main Authors Gupta, Nilesh, Liu, Jeffrey R., Patel, Brijeshkumar, Solomon, Deepak E., Vaidya, Bhuvaneshwar, Gupta, Vivek
Format Journal Article
LanguageEnglish
Published United States John Wiley & Sons, Inc 01.03.2016
John Wiley and Sons Inc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The implementation of microfluidic devices within life sciences has furthered the possibilities of both academic and industrial applications such as rapid genome sequencing, predictive drug studies, and single cell manipulation. In contrast to the preferred two‐dimensional cell‐based screening, three‐dimensional (3D) systems have more in vivo relevance as well as ability to perform as a predictive tool for the success or failure of a drug screening campaign. 3D cell culture has shown an adaptive response to the recent advancements in microfluidic technologies which has allowed better control over spheroid sizes and subsequent drug screening studies. In this review, we highlight the most significant developments in the field of microfluidic 3D culture over the past half‐decade with a special focus on their benefits and challenges down the lane. With the newer technologies emerging, implementation of microfluidic 3D culture systems into the drug discovery pipeline is right around the bend.
Bibliography:Funding information
VG acknowledges support by KGI School of Pharmacy (Research Start‐up funds).
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
Funding information VG acknowledges support by KGI School of Pharmacy (Research Start‐up funds).
ISSN:2380-6761
2380-6761
DOI:10.1002/btm2.10013